News | January 07, 2008

Public Forum on CTA Reimbursement to Close Jan. 12

January 8, 2008 – The cardiac imaging community has until Jan. 12 to contribute to the Centers for Medicare and Medicaid Services (CMS) public comments forum regarding CMS’ proposed National Coverage Decision (NCD) that would limit reimbursement for coronary CTA to just two clinical indications.

In the decision, CMS states that “[t]he evidence is inadequate to conclude that cardiac computed tomographic angiography (CTA) is reasonable and necessary under section 1862(a)(1)(A) for the diagnosis of coronary artery disease (CAD).”

Under the proposal, the only two reimbursable indications would be CTA for the diagnosis of CAD for symptomatic patients with chronic stable angina at intermediate risk of CAD; or symptomatic patients with unstable angina at a low risk of short-term death and intermediate risk of CAD. CMS would only provide the coverage with evidence development (CED) appropriate for these indications based on the specific standards.

Many clinicians in the cardiac community argue that CMS has not examined the full impact this proposal will have on the Medicare beneficiary, and are urging others to send in their comments to encourage CMS to suspend its proposed NCD for two years and consider more than 25 studies published in 2007 that were left out of the agency’s assessment of coronary CTA.

To contribute to the public comments forum, go to http://www.cms.hhs.gov/mcd/public_comment.asp?nca_id=206&basketitem=nca:00385n:206:computed tomographic angiography:open:new:5.

For more information: www.cms.hhs.gov


Additional Content

News | CT Angiography (CTA)

Nov. 3, 2026 — Elucid has announced results from ELUCIDATE at the annual Transcatheter Cardiovascular Therapeutics ...

Home November 04, 2026
Home
News | CT Angiography (CTA)

July 29, 2026 — Caristo Diagnostics has announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Home July 30, 2026
Home
News | CT Angiography (CTA)

July 9, 2026 — Elucid recently announced first patient enrollment in AI-Predict, a retrospective, international ...

Home July 13, 2026
Home
Feature | CT Angiography (CTA) | Kyle Hardner

Advances in coronary CT angiography (CCTA) over the past two decades have helped cardiologists detect heart disease in ...

Home February 06, 2026
Home
News | CT Angiography (CTA)

Jan. 9, 2026 — Effective January 1, 2026, Elucid's Plaque-IQ coronary plaque analysis has received a new Category I ...

Home January 09, 2026
Home
Subscribe Now